Autres langues Organogenesis Holdings Inc.

Actions

ORGO

US68621F1021

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 01/05/2024			Varia. 5j.	Varia. 1 janv.
2,51 ^USD	+6,81%		-15,77%	-38,63%

29/02	Transcript : Organogenesis Holdings Inc., Q4 2023 Earnings Call, Feb 29, 2024
29/02	Organogenesis Holdings Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024	16/04
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case	03/04
Organogenesis: Q4 Earnings Snapshot	29/02
Organogenesis Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q4 Revenue $99.7M, vs. Street Est of $109.1M	29/02
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance	29/02
Organogenesis Holdings Inc. Provides Earnings Guidance for the First Quarter and for the Year Ending December 31, 2024	29/02
Organogenesis Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference	12/02
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024	08/02
Organogenesis Holdings Insider Sold Shares Worth $940,860, According to a Recent SEC Filing	11/01
HippoFi Hires World's Top Regenerative Therapy Expert, Dr. Gail Naughton, to Drive Commercialization Plans of its Proprietary Technologies	12/12
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	07/12
Organogenesis: Q3 Earnings Snapshot	09/11
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q3 Revenue $108.5M, vs. Street Est of $111.4M	09/11
Organogenesis Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results	09/11
Organogenesis Holdings Inc. Provides Earnings Guidance for the Year Ending December 31, 2023	09/11
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023	05/10/23
Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS	28/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Organogenesis Holdings Inc.

Actions

ORGO

US68621F1021

Autres langues

Filtres